Blood Transfusion in Cardiac Surgery
2007; Lippincott Williams & Wilkins; Volume: 116; Issue: 22 Linguagem: Inglês
10.1161/circulationaha.107.739094
ISSN1524-4539
Autores Tópico(s)Cardiac and Coronary Surgery Techniques
ResumoHomeCirculationVol. 116, No. 22Blood Transfusion in Cardiac Surgery Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBBlood Transfusion in Cardiac SurgeryA Silent Epidemic Revisited James D. Rawn James D. RawnJames D. Rawn From the Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. Originally published27 Nov 2007https://doi.org/10.1161/CIRCULATIONAHA.107.739094Circulation. 2007;116:2523–2524Mr Corazon is a 78-year-old man with insulin-dependent diabetes mellitus and an ejection fraction of 40% who is postoperative day 2 from coronary artery bypass grafting. He has been extubated and feels good, but he remains on a low-dose epinephrine infusion to support his blood pressure. His cardiac index is 2.2 L/m2, and he has a mixed venous oxygen saturation of 59%. He has low filling pressures and marginal urine output. His hematocrit is 24%. His surgeon and his cardiologist confer and agree to transfuse him with 1 unit of red blood cells. They explain to him that he needs the blood transfusion and that the major risk of transfusion is the very low risk of viral infection. After the transfusion, his mixed venous oxygen saturation and urine output improve, and his epinephrine infusion is weaned off. He is transferred out of the intensive care unit the following day.Article p 2544The rationale for transfusing Mr Corazon is understandable. Historically, patients were thought to benefit from transfusions that boosted their hematocrit to ≥30%, particularly if they were older and sicker. Transfused blood is an excellent volume expander and remains in the intravascular space better than other resuscitation fluids. Transfused patients often "look better." It is possible that Mr Corazon's transfusion allowed his hemodynamics to improve sufficiently to wean him more quickly from his inotropic support. We might even expect that his recovery has been accelerated and his length of stay reduced.How should we evaluate this decision making in light of the available evidence? The article by Murphy et al1 in the current issue of Circulationfound no benefit from transfusion for hematocrits as low as 21% (hemoglobin of 7 g/dL), and the risk of death within 30 days of surgery was almost 6 times greater for patients who received blood. In addition, transfused patients were more likely to experience increased infections and ischemic complications (myocardial infarction, renal compromise, and stroke). This study joins a decade of observational studies demonstrating an association between red blood cell transfusion and adverse outcomes in cardiac surgery.2–5 In a dose-dependent and often durable manner, red blood cell transfusion in cardiac surgery patients has been linked as an independent variable to an increase in infectious complications, myocardial infarction, stroke, renal failure, prolonged ventilation, atrial fibrillation, hospital length of stay, and mortality. Although the immediate impact on survival is significantly greater, transfusion with as little as 1 unit of red blood cells has been associated with decreased 10-year survival after coronary artery bypass grafting.6 It has been difficult to find evidence of benefit.The studies linking transfusion to cardiac surgery outcomes are retrospective; despite careful risk adjustment, it is possible that these associations reflect a tendency among clinicians to transfuse the most critically ill patients or miss another important confounder. One cautionary tale involves a study by the Northern New England Cardiovascular Disease Study Group that initially stimulated an increase in blood transfusion when it was reported that the lowest hematocrit on bypass was correlated with increased mortality and postoperative heart failure.7 Subsequent analysis has suggested that although anemia is a marker for poor outcomes, the tendency for anemic patients to be transfused explains much of the association; moreover, blood transfusions were associated with postoperative requirements for mechanical and inotropic support regardless of the degree of anemia.8The Transfusion Requirements in Critical Care trial is important because it is a prospective randomized trial that supports a causal link between blood transfusion and adverse outcomes in critically ill patients. When patients were randomized to liberal (transfusion threshold of hemoglobin <10 g/dL) or restrictive (transfusion threshold <7 g/dL) transfusion groups, cardiac and pulmonary complications increased significantly and a trend existed toward increased mortality in the liberal transfusion group. When younger (<55 years of age) or less critically ill (Acute Physiology, Age, Chronic Health Evaluation [APACHE] score 65 years of age treated for acute myocardial infarction if they received blood transfusions when their admission hematocrit was 25%.The present study found that ischemic complications (myocardial infarction, neurological and renal injury) were not decreased with blood transfusion regardless of the patient's nadir hematocrit or comorbidities. The lack of benefit from blood transfusions in decreasing these complications might be explained because hemoglobin levels rarely limit oxygen delivery given the transfusion triggers that predominate in cardiac surgery.14 Possible mechanisms for the contribution of transfusion to ischemic complications include proinflammatory effects and storage defects. Stored red blood cells are 2,3-DPG deficient and consequently less adept at unloading oxygen and less deformable, possibly leading to sludging and capillary occlusion.The association of blood transfusion with infection confirms previous reports. The mechanism is presumably the result of immunosuppressive effects. Blood was used to decrease the incidence of rejection in the early days of kidney transplantation, and transfusion has been associated with cancer recurrence and death in patients with malignancy.In an effort to conserve a limited and expensive resource and to minimize the injury caused by transfusion therapy, the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists have joined forces and, with impressive effort, have produced a clinical practice guideline. Their guideline emphasizes that the benefits of transfusion have not been adequately demonstrated and that existing evidence is an imperfect guide to transfusion decisions. They suggest a transfusion trigger of hemoglobin <7 g/dL in postoperative cardiac surgery patients (class IIa recommendation). In addition, they suggest (class IIb recommendation) that it is "not unreasonable to transfuse red cells in certain patients with critical noncardiac end-organ ischemia (eg, central nervous system and gut) whose hemoglobin levels are as high as 10 g/dL, but more evidence to support this recommendation is required."15 The present study suggests that more evidence may be hard to find.In 2001, Spiess16 referred to current transfusion practices as "a silent epidemic." His description is still accurate. In 2006, almost half of all patients undergoing coronary bypass grafting in the United States received blood transfusions, and the probability of receiving blood is greater when procedures are more complex. When making clinical decisions, physicians tend to focus more on their patients' immediate clinical status than on Kaplan–Meier curves. Although the infectious risks of blood transfusion have been successfully minimized, the weight of the evidence increasingly suggests that transfusing less in stable patients could prevent a significant amount of morbidity and mortality. The Society of Thoracic Surgeons/Society of Cardiovascular Anesthesiologists clinical practice guideline provide valuable strategies for minimizing bleeding in the perioperative period. The experience with Jehovah Witnesses demonstrates that when a commitment is made to avoid blood transfusion, the effort is successful in the vast majority of cases. Recognition that blood transfusion poses significant risk for what is frequently an uncertain benefit can inspire a similar level of commitment.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.DisclosuresNone.FootnotesCorrespondence to James D. Rawn, MD, Division of Cardiac Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02155. E-mail [email protected] References 1 Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007; 116: 2544–2552.LinkGoogle Scholar2 Murphy GJ, Angelini GD. Indications for blood transfusion in cardiac surgery. Ann Thorac Surg. 2006; 82: 2323–2334.CrossrefMedlineGoogle Scholar3 Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002; 74: 1180–1186.CrossrefMedlineGoogle Scholar4 Koch CG, Liang L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006; 34: 1608–1616.CrossrefMedlineGoogle Scholar5 Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM, Blackstone EH. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg. 2006; 82: 1747–1756.CrossrefMedlineGoogle Scholar6 Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ, Blackstone EH. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg. 2006; 81: 1650–1657.CrossrefMedlineGoogle Scholar7 Defoe GR, Ross CS, Olmstead EA, Surgenor SD, Fillinger MP, Groom RC, Forest RJ, Pieroni JW, Warren CS, Bogosian ME, Krumholz CF, Clark C, Clough RA, Weldner PW, Lahey SJ, Leavitt BJ, Marrin CA, Charlesworth DC, Marshall P, O'Connor GT. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg. 2001; 71: 769–776.CrossrefMedlineGoogle Scholar8 Surgenor SD, DeFoe GR, Fillinger MP, Likosky DS, Groom RC, Clark C, Helm RE, Kramer RS, Leavitt BJ, Klemperer JD, Krumholz CF, Westbrook BM, Galatis DJ, Frumiento C, Ross CS, Olmstead EM, O'Connor GT. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation. 2006; 114 (suppl I): I-43–I-48.LinkGoogle Scholar9 Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999; 340: 409–417.CrossrefMedlineGoogle Scholar10 Hébert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, Tweeddale M, Pagliarello G, Schweitzer I. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001; 29: 227–234.CrossrefMedlineGoogle Scholar11 Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001; 345: 1230–1236.CrossrefMedlineGoogle Scholar12 Yang X, Alexander KP, Chen AY, Roe MT, Brindis RG, Rao SV, Gibler WB, Ohman EM, Peterson ED, for the CRUSADE Investigators. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol. 2005; 46: 1490–1495.CrossrefMedlineGoogle Scholar13 Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004; 292: 1555–1562.CrossrefMedlineGoogle Scholar14 Mathru M, Kleinman B, Blakeman B, Sullivan H, Kumar P, Dries DJ. Myocardial metabolism and adaption during extreme hemodilution in humans after coronary revascularization. Crit Care Med. 1992; 20: 1420–1425.CrossrefMedlineGoogle Scholar15 Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, Saha SP, Hessel EA 2nd, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR, for the Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007; 83: S27–S86.CrossrefMedlineGoogle Scholar16 Spiess BD. Blood transfusion: the silent epidemic. Ann Thorac Surg. 2001; 72: S1832–S1837.CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Rammell J, Perre D, Boylan L, Prentis J, Nesbitt C, Elmallah A and Nandhra S (2022) The adverse impact of pre-operative anaemia on survival following major lower limb amputation, Vascular, 10.1177/17085381211065622, 31:2, (379-386), Online publication date: 1-Apr-2023. Cowart C and Roberts S (2023) Pro: Modified Ultrafiltration Is Beneficial for Adults Undergoing Cardiac Surgery, Journal of Cardiothoracic and Vascular Anesthesia, 10.1053/j.jvca.2023.01.014, Online publication date: 1-Jan-2023. Kupryashov А, Samuilova О and Samuilova D (2021) Optimal blood management as priority route in cardiac surgery, Russian journal of hematology and transfusiology, 10.35754/0234-5730-2021-66-3-395-416, 66:3, (395-416) Latif A, Kapoor V, Lateef N, Ahsan M, Usman R, Malik S, Ahmad N, Rosko N, Rudoni J, William P, Khouri J and Anwer F Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis, Cardiovascular & Hematological Disorders-Drug Targets, 10.2174/1871529X21666210412113017, 21:1, (30-45) (2021) Mediastinal Bleeding Manual of Perioperative Care in Adult Cardiac Surgery, 10.1002/9781119582540.ch9, (417-455), Online publication date: 8-Jan-2021. (2021) General Preoperative Considerations and Preparation of the Patient for Surgery Manual of Perioperative Care in Adult Cardiac Surgery, 10.1002/9781119582540.ch3, (173-216), Online publication date: 8-Jan-2021. Fabbro M, Damluji A, Cohen M and Epstein R (2018) Cardiorespiratory Stability of Patients Undergoing Transcatheter Aortic Valve Replacement Is Not Improved During General Anesthesia Compared to Sedation: A Retrospective, Observational Study, Structural Heart, 10.1080/24748706.2018.1438688, 2:3, (205-211), Online publication date: 1-May-2018. Chandra S, Kulkarni H and Westphal M (2017) The bloody mess of red blood cell transfusion, Critical Care, 10.1186/s13054-017-1912-x, 21:S3, Online publication date: 1-Dec-2017. Bartoszko J and Karkouti K (2017) Can predicting transfusion in cardiac surgery help patients?, British Journal of Anaesthesia, 10.1093/bja/aex216, 119:3, (350-352), Online publication date: 1-Sep-2017. (2016) The Negative Influence and Adverse Outcome of Blood Transfusion in Heart Surgery Patients, Journal of Cardiology & Current Research, 10.15406/jccr.2016.07.00241, 7:2 Schotola H, Wetz A, Popov A, Bergmann I, Danner B, Schöndube F, Bauer M and Bräuer A (2016) The Effects of Residual Pump Blood on Patient Plasma Free Haemoglobin Levels Post Cardiac Surgery, Anaesthesia and Intensive Care, 10.1177/0310057X1604400519, 44:5, (587-592), Online publication date: 1-Sep-2016. Thongprayoon C, Cheungpasitporn W, Gillaspie E, Greason K and Kashani K (2016) Association of blood transfusion with acute kidney injury after transcatheter aortic valve replacement: A meta-analysis, World Journal of Nephrology, 10.5527/wjn.v5.i5.482, 5:5, (482), . Georgiou C and Irons J (2015) Priming solutions for cardiopulmonary bypass circuits Cardiopulmonary Bypass, 10.1017/CBO9781139871778.004, (42-50) Geissler R, Rotering H, Buddendick H, Franz D, Bunzemeier H, Roeder N, Kwiecien R, Sibrowski W, Scheld H, Martens S and Schlenke P (2015) Utilisation of Blood Components in Cardiac Surgery: A Single-Centre Retrospective Analysis with Regard to Diagnosis-Related Procedures, Transfusion Medicine and Hemotherapy, 10.1159/000377691, 42:2, (75-82), . Jakobsen C (2014) Transfusion Strategy: Impact of Haemodynamics and the Challenge of Haemodilution, Journal of Blood Transfusion, 10.1155/2014/627141, 2014, (1-12), Online publication date: 6-Aug-2014. Kneyber M, Grotenhuis F, Berger R, Ebels T, Burgerhof J and Albers M (2013) Transfusion of Leukocyte-Depleted RBCs Is Independently Associated With Increased Morbidity After Pediatric Cardiac Surgery*, Pediatric Critical Care Medicine, 10.1097/PCC.0b013e3182745472, 14:3, (298-305), Online publication date: 1-Mar-2013. Jakobsen C, Ryhammer P, Tang M, Andreasen J and Mortensen P (2012) Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients, European Journal of Cardio-Thoracic Surgery, 10.1093/ejcts/ezr242, 42:1, (114-120), Online publication date: 1-Jul-2012. Paone G, Brewer R, Theurer P, Bell G, Cogan C and Prager R (2012) Preoperative predicted risk does not fully explain the association between red blood cell transfusion and mortality in coronary artery bypass grafting, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2011.09.015, 143:1, (178-185), Online publication date: 1-Jan-2012. Vuylsteke A, Pagel C, Gerrard C, Reddy B, Nashef S, Aldam P and Utley M (2011) The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding, European Journal of Cardio-Thoracic Surgery, 10.1016/j.ejcts.2010.10.003, 39:6, (924-930), Online publication date: 1-Jun-2011. Dietrich W (2010) Autologous Blood Predonation in Cardiac Surgery Alternatives to Blood Transfusion in Transfusion Medicine, 10.1002/9781444319583.ch46, (569-574) van Straten A, Bekker M, Soliman Hamad M, van Zundert A, Martens E, Schönberger J and de Wolf A (2010) Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up, Interactive CardioVascular and Thoracic Surgery, 10.1510/icvts.2009.214551, 10:1, (37-42), Online publication date: 1-Jan-2010. Senay S, Toraman F, Karabulut H and Alhan C (2010) Is it the patient or the physician who cannot tolerate anemia? A prospective analysis in 1854 non-transfused coronary artery surgery patients, Perfusion, 10.1177/0267659109358118, 24:6, (373-380), Online publication date: 1-Nov-2009. Thomson A, Farmer S, Hofmann A, Isbister J and Shander A (2009) Patient blood management - a new paradigm for transfusion medicine?, ISBT Science Series, 10.1111/j.1751-2824.2009.01251.x, 4:n2, (423-435), Online publication date: 1-Nov-2009. Hallward G and Hall R (2009) Priming solutions for cardiopulmonary bypass circuits Cardiopulmonary Bypass, 10.1017/CBO9780511635564.004, (36-40) (2008) Current World Literature, Current Opinion in Anaesthesiology, 10.1097/ACO.0b013e328312c01b, 21:5, (684-693), Online publication date: 1-Oct-2008. November 27, 2007Vol 116, Issue 22 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.107.739094PMID: 18040038 Originally publishedNovember 27, 2007 Keywordskidneyblood cellsinfectionEditorialsinfarctionsurgeryPDF download Advertisement SubjectsAcute Coronary SyndromesCardiorenal SyndromeCardiovascular SurgeryIschemic StrokeMyocardial Infarction
Referência(s)